Targeting the HER1/EGFR receptor to improve outcomes in non-small-cell lung cancer.

@article{Gatzemeier2003TargetingTH,
  title={Targeting the HER1/EGFR receptor to improve outcomes in non-small-cell lung cancer.},
  author={Ulrich Gatzemeier},
  journal={Oncology},
  year={2003},
  volume={17 11 Suppl 12},
  pages={7-10}
}
Non-small-cell lung cancer represents a growing global burden and remains a therapeutic challenge. Only small improvements in survival have been made with standard chemotherapeutic approaches to advanced disease in recent history. Novel biologic targeted therapies offer the potential of improving patient management and treatment outcomes in non-small-cell lung cancer. Prominent among these novel agents are the HER1/epithelial growth factor receptor (EGFR) inhibitors. One of these agents… CONTINUE READING